What is the GMED stock price prediction for next 2 weeks?

According to our price prediction algorithm,Globus Medical, Inc. (GMED) price will be around $87.49 in the next 2 weeks. This means it will increase by 0.491040661612675 from the last closing price. This prediction may vary from other time period filters for GMED stock.

What can be the highest Possible price of GMED stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, GMED can achieve the highest price of $92.63 which is 6.398211958844581 higher than last closing price. This prediction may vary from other time period filters for GMED stock.

What can be the lowest Possible price of GMED stock in next 2 weeks?

As per the forecast and algorithmic analysis, GMED stock price can be as low as $82.15 which is -5.635010837321542 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for GMED stock.

Will GMED stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that GMED stock will gain0.491040661612675 in the next 2 weeks. This prediction may vary from other time period filters for GMED stock.

What is GMED stock last closing price?

Last closing price of GMED stock was $87.06.

What is GMED stock price prediction?

GMED stock price prediction means predicting the future closing prices of GMED stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of GMED stock in a certain time period.

How we predict GMED stock future prices?

If you are searching for GMED stock forecast, analysis or price prediction, then you might be wondering what Globus Medical, Inc. (GMED) will do in the future. Our GMED price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This GMED price prediction will likely answer most of your questions.

How frequent we update GMED stock predictions?

We are updating the forecasts for the GMED stock on daily basis.

Is using ML forecasting for GMED stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for GMED stock same for all the time periods?

No, the prediction for GMED stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Globus Medical, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$87.06-2.18%Since 2 Weeks

Predicted Price$87.490.49%For 2 Weeks

Upper Predicted Price$92.636.4%For 2 Weeks

Lower Predicted Price$82.15-5.64%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of GMED will rise by +0.49% over the next 2 Weeks and hit $87.49 by Friday, January 2, 2026. In that time frame, GMED's share price is expected to range between $82.15 and $92.63.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jan 2, 2026	82.07	87.49	92.68
Jan 1, 2026	78.48	83.81	89.08
Dec 31, 2025	79.52	84.38	89.43
Dec 30, 2025	79.14	84.02	89.39
Dec 29, 2025	80.35	85.77	90.61
Dec 26, 2025	82.16	87.29	92.32
Dec 25, 2025	78.39	83.61	88.51
Dec 24, 2025	79.21	84.18	89.07
Dec 23, 2025	79.17	83.82	88.68
Dec 22, 2025	80.65	85.57	90.20

GMED shares rose +2.78% in Monday, December 22, 2025's trading session, rising from a previous close of $87.06 to move at $89.48. The stock demonstrated notable intraday movement (see GMED's key stats for a full breakdown), fluctuating between $87.23 and $89.85, a +3.00% trading range. While recent weeks have seen some volatility, GMED has managed to secure a -1.78% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 2.5M shares changing hands, 801.18K more than the previous session. This amounted to $223.45M in total market activity.

Will GMED Continue Its Upward Trend?

According to analyst ratings and projections for GMED, Globus Medical, Inc. shares are anticipated to increase by +3.45%, potentially reaching $92.68 per share by January 2, 2026. Short-term technical indicators currently suggest a neutral sentiment for GMED. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the GMED stock forecast, now is a good time to buy GMED stock because its current trading price is +2.28% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on GMED covering social and institutional perspectives.

GMED Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into GMED's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 62.96% to 64.92%) suggest the stock is in a bullish momentum phase. The 50-day RSI, at 63.24%, suggests strong medium-term momentum. Additionally, the 100-day RSI, at 58.44%, maintains a neutral outlook for the long term. Insights into GMED's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Globus Medical Short-Term Forecasts

GMED Forecast For Next 5 Days

Our algorithm anticipates Globus Medical (GMED) stock could hit $82.37 by Dec 29, 2025. This represents a -7.95% fall from today's price, following a -2.05% change over the past five days.

GMED Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Globus Medical, Inc. (GMED) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $89.45, which would mean a -0.03% decrease from the current price of $89.48. Projections for this period range from a high of $107.39 to a low of $72.94.

GMED Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Globus Medical's price over the next three months point to a drop. GMED stock is expected to peak at $93.52 on Mar 13, 2026 after potentially dipping to $80.56 on Dec 25, 2025. On average, GMED is likely to trade around $87.66 in the coming 90 days.

Globus Medical Stock Forecast 2025

Based on our predictive models, Globus Medical (GMED) is expected to trade between $80.56 and $90.12 throughout 2025. This would result in an average price of $85.38, potentially offering investors a -4.58% return from current levels.

Globus Medical, Inc. Monthly Forecast 2025–2026

December 2025

According to our latest forecast models, Globus Medical, Inc. (GMED) is positioned to show a strong performance in December 2025. The price is predicted to move between $80.56 and $90.12, settling at an average of $85.38. This could translate to a -4.58% loss.

January 2026

Based on current market signals, Globus Medical, Inc. is projected to trend january 2026. We forecast a trading range from $81.77 to $93.26, with a likely average price of $87.45. Investors could expect a potential return of -2.27%.

February 2026

Our predictive algorithms indicate Globus Medical, Inc. stock may see a shift in February 2026. The expected range spans $83.29–$93.49, with an average target of $88.18. This represents a cautious outlook and a possible loss of -1.45%.

March 2026

Analyzing established trends, Globus Medical, Inc. looks set to move in March 2026. Projections place the stock between $83.38 and $93.52, averaging around $88.47. This suggests a -1.13% loss from current levels.

April 2026

Market indicators suggest Globus Medical, Inc. could experience notable changes during April 2026. Prices could fluctuate within $84.20 to $97.12, with a midpoint forecast of $90.95. The stock might deliver a +1.64% gain.

May 2026

Forecasting for May 2026, models estimate that Globus Medical, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $81.90 and $96.13, averaging $89.33. This signals a cautious trajectory with potential returns around -0.17%.

June 2026

According to our latest forecast models, Globus Medical, Inc. (GMED) is positioned to show a strong performance in June 2026. The price is predicted to move between $83.02 and $94.46, settling at an average of $89.09. This could translate to a -0.44% loss.

July 2026

Based on current market signals, Globus Medical, Inc. is projected to trend july 2026. We forecast a trading range from $84.97 to $95.10, with a likely average price of $89.91. Investors could expect a potential return of +0.48%.

August 2026

Our predictive algorithms indicate Globus Medical, Inc. stock may see a shift in August 2026. The expected range spans $84.81–$95.63, with an average target of $90.12. This represents a positive outlook and a possible gain of +0.72%.

September 2026

Analyzing established trends, Globus Medical, Inc. looks set to move in September 2026. Projections place the stock between $86.02 and $99.07, averaging around $92.85. This suggests a +3.77% gain from current levels.

October 2026

Market indicators suggest Globus Medical, Inc. could experience notable changes during October 2026. Prices could fluctuate within $83.60 to $97.43, with a midpoint forecast of $90.36. The stock might deliver a +0.98% gain.

November 2026

Forecasting for November 2026, models estimate that Globus Medical, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $85.46 and $110.06, averaging $91.67. This signals a positive trajectory with potential returns around +2.45%.

December 2026

According to our latest forecast models, Globus Medical, Inc. (GMED) is positioned to show a strong performance in December 2026. The price is predicted to move between $86.62 and $96.70, settling at an average of $91.46. This could translate to a +2.21% gain.

GMED's history of dividends and stock splits also plays a role in long-term investor confidence.